FDA Funding Increase Hangs In Balance As Congress Eyes Another CR

House and Senate appropriations panels are both pushing funding increases for FDA, but whether the agency will get additional money for fiscal 2020 hangs in the balance as lawmakers eye at least one more short-term continuing resolution (CR) and the prospects of individual appropriations bills remains unclear. FDA experts predict Congress will pass another CR on the Nov. 21 deadline and will try to reach a decision about FDA appropriations by the end of the year, but they say more...